Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries by Alexandra Cameron, Ilse Roubos, Margaret Ewen, Aukje K Mantel-Teeuwisse, Hubertus GM Leufkens, Richard O Laing

Get full text

Using government data to understand the use and availability of medicines for hypertension and diabetes: lessons from Peru by Janeth Tenorio-Mucha, María Lazo-Porras, Jessica Zafra, Margaret Ewen, David Beran

Get full text

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries by Shanti Mendis, Keiko Fukino, Alexandra Cameron, Richard Laing, Anthonio Filipe Jr, Oussama Khatib, Jerzy Leowski, Margaret Ewen

Get full text

Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. by Margaret Ewen, Marjolein Zweekhorst, Barbara Regeer, Richard Laing

“…We undertook a secondary analysis of data from 30 surveys in low- and middle-income countries, conducted from 2008-2015 using the World Health Organization (WHO)/Health Action International (HAI) medicine availability and price survey methodology, to establish a baseline for this target. …”
Get full text